CGON vs VRTX: Which Stock is Better?
Side-by-side comparison of CG Oncology, Inc. Common stock and Vertex Pharmaceuticals Inc in 2026
CGON
CG Oncology, Inc. Common stock
—
VRTX
Vertex Pharmaceuticals Inc
$528.04
Key Metrics Comparison
| Metric | CGON | VRTX | Winner |
|---|---|---|---|
| Market Cap | $4.74B | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CGON
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGON or VRTX a better investment?
Comparing CGON and VRTX: CG Oncology, Inc. Common stock has a market cap of $4.74B while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGON and VRTX?
CGON (CG Oncology, Inc. Common stock) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGON or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGON or VRTX?
Both CGON and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CGON or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CGON or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $4.74B for CGON.
Should I buy CGON or VRTX in 2026?
Both CGON and VRTX have investment merit. CGON trades at $N/A while VRTX trades at $528.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGON and VRTX stock?
Key differences: Market Cap ($4.74B vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CGON or VRTX in 2026?
The choice between CGON and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CGON and VRTX?
CGON (CG Oncology, Inc. Common stock) has a market cap of $4.74B, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.